Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07468409

JASPER™ Robotic Surgical System (Formerly Known as the ORYOM™ Robotic Surgical System) in Cataract Surgery

This is a prospective, open-label clinical study designed to evaluate the performance and safety of the JASPER™ Robotic Surgical System during cataract surgery.

Recruiting

Interested in participating?

Request Info

Key information

Age range

55 year–80 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Asian Eye Instiitute

Makati City, National Capital Region, 1200, Philippines

Location status: Recruiting

Location contact

Robert Ang, Dr.

CONTACT

[email protected]

(02) 8-898-2020

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Main Inclusion Criteria:

  • Patient aged 55 to 80 years
  • Willing and able to sign an informed consent, attend the clinic and comply with all study procedures and the study protocol
  • Patients are scheduled to undergo cataract surgery
  • Clear intraocular media, other than cataract
  • Pupil dilate according to stand of care

Main Exclusion Criteria:

  • Prior ocular surgery or trauma in the study eye
  • Polar cataract in the study eye
  • Zonular instability or significant anterior segment abnormalities
  • Active ocular infection or uveitis
  • Pseudoexfoliation (PXF) syndrome in either eye
  • ASA Physical Status Classification > 3
  • Participation in another clinical trial within 30 days

Treatment and study plan

JASPER™ Robotic Surgical System

Device

The JASPER™ Robotic Surgical System is a robotically assisted surgical system intended to assist ophthalmic surgeons in performing cataract surgery.

Primary outcomes

  1. Successful completion of planned Robotic-Assisted cataract surgery

    Time frame: Intra-operative

    Proportion of study eyes in which the planned robotic cataract surgery is completed using the JASPER™ Robotic Surgical System without conversion to manual technique.

Secondary outcomes

  1. Incidence and Type of Adverse Events (AEs) and Serious Adverse Events (SAEs)

    Time frame: From surgery through 30 days post-procedure

    Incidence and type of all AEs and SAEs occurring intraoperatively and during the postoperative follow-up period.

  2. Distribution of pre and postoperative Best Corrected Visual acuity

    Time frame: Baseline and up to 30 days post-procedure

    Distribution of preoperative and postoperative BCVA

  3. Postoperative Ophthalmic examination findings

    Time frame: Up to 30 days post-procedure

    Postoperative slit lamp and dilated fundus examinations findings

Study contacts

Contact information is provided by the study sponsor or research team.

Merav Gat, M.Sc., MBA

CONTACT

[email protected]

+972547800259

Sponsors and collaborators

Lead sponsor

ForSight Robotics Ltd

Industry

Registry information

Official study title

Single-site, Open-label, Prospective Feasibility Study Performed Using the JASPER™ Robotic Surgical System in Cataract Surgery Procedures

Important dates

Study start
2026
Primary completion
2027
Study completion
2027
First posted
Mar 12, 2026
Registry last updated
Jul 24, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.